Hannes Teissl

Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands.

ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands.

Bioceros Holding BV develops monoclonal antibodies and generating GMP-ready cell lines. engages in building therapeutic monoclonal antibodies, including targets in oncology and auto-immune diseases. It generates various cell lines that produce proteins ranging from blood proteins and monoclonal antibodies to fusion proteins. The company is headquartered in Utrecht, the Netherlands.

Akrikhin Pharmaceuticals OAO engages in the production of pharmaceutical products. Its portfolio focuses on cardiology, neurology, dermatology, gynecology, and pediatrics. The firm also manufactures drugs for diabetes and tuberculosis treatment. The company was founded in 1936 and is headquartered in Moscow, Russia.

Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria.